EBV infection induces immortalization of human lymphocytes without killing the cells. On the other hand, treatment of viral genome carrying cells with TPA, or superinfection of such cells with HR-1 virus induces lytic infection which ultimately destroys these cells. Our previous studies indicated that genes residing in the BamHI M fragments (M genes) appear to be playing an important role in the direction of EBV infection, i.e. immortalization or lytic infection. Our recent study also indicated that HRI virus DNA contains 3 BamHI M fragments different in size from standard transforming virus DNA. This suggests that the structural alteration of BamHI M may cause the expression of M genes immediately after superinfection of Raji cells with HRI virus. In this proposal, we plan to study in more detail about the M genes of HR-1 (super-infecting) and B95 (immortalizing) EBV. Detailed structural study of M genes of HR-1 and B95 EBV will be conducted to determine what difference exists between HR-1 M and B95 M genes. To further study transcriptional control of EBV genes including M genes, in vitro transcriptional system will be used. This study may identify any control factors involved in EBV gene transcription. Finally, M gene products will be identified by in vivo labeling of M gene proteins after treatment with and subsequently release from cyclohexamide of superinfected cells or by Cos-1 cell system with pSVOd or pSVO10 vector. The M gene proteins will be expressed in SV40 vector systems or cDNA-bacterial plasmid vector system. The proteins will be purified and tested for biochemical activities such as DNA binding property, protein kinase activity and transcription stimulating activity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA031950-05
Application #
3170058
Study Section
Virology Study Section (VR)
Project Start
1981-08-01
Project End
1987-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Tampa Bay Research Institute
Department
Type
DUNS #
City
Saint Petersburg
State
FL
Country
United States
Zip Code
33716
Nonoyama, M; Wen, L T; Tanaka, A et al. (1990) Detection of 12-o-tetradecanoylphorbol-13-acetate-induced cellular proteins that compete with the Epstein-Barr virus nuclear antigen 1 (EBNA-1) for binding to a site within the Epstein-Barr virus oriP. Adv Exp Med Biol 278:125-36
Wen, L T; Lai, P K; Bradley, G et al. (1990) Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins. Virology 178:293-6
Wen, L T; Tanaka, A; Nonoyama, M (1989) Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells. J Virol 63:3315-22
Bradley, G; Lancz, G; Tanaka, A et al. (1989) Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H. J Virol 63:4129-35
Bradley, G; Hayashi, M; Lancz, G et al. (1989) Structure of the Marek's disease virus BamHI-H gene family: genes of putative importance for tumor induction. J Virol 63:2534-42
Yamamoto, M; Tabata, T; Smith, M et al. (1989) Cycloheximide-resistant gene of Epstein-Barr virus in freshly infected B lymphocytes. Virology 170:307-10
Sawada, K; Yamamoto, M; Tabata, T et al. (1989) Expression of EBNA-3 family in fresh B lymphocytes infected with Epstein-Barr virus. Virology 168:22-30
Wen, L T; Tanaka, A; Nonoyama, M (1988) Identification of Marek's disease virus nuclear antigen in latently infected lymphoblastoid cells. J Virol 62:3764-71
Nonoyama, M; Wen, L T; Tabata, T et al. (1988) A novel EBNA-1 titration method and putative anti-EBNA-1 protein. J Virol Methods 21:161-70
Harada, H; Sawada, K; Kudo, S et al. (1987) Development of cell systems to study viral gene transcription at the initial phase of Epstein-Barr virus infection. Virus Genes 1:73-82

Showing the most recent 10 out of 13 publications